Dr. Mahajan is a professor and vitreoretinal surgeon in the Department of Ophthalmology at Stanford University. He is the Vice Chair for Research and directs the Molecular Surgery Program and the NIH-funded Omics Laboratory that uses high-throughput methods in proteomics, genomics, and phenomics to identify molecules involved in eye disease. The lab uses protein crystallography and structural modeling to design therapeutic inhibitors that can be tested in stem cell and transgenic animal disease models. His team also created the TEMPO precision health tool that integrates human proteomics with single cell gene expression to identify molecular pathways active in living humans. Mahajan’s multidisciplinary team helps translate laboratory studies into human clinical trials at Stanford and through the founding and support of biomedical start-ups.